Avid Bioservices Inc (CDMO)

[cjgaddy]

2 Oral-pres. this-wk: TODAY=Hutchins(Preclin), Sat=Yopp(Liver/Ph2)

Mar25/Wed: Immune Checkpoint Inhibitors (ICI) Forum (designed with Merck, BMS, Genentech, Novartis, EMD-Serono, Amgen), Boston http://tinyurl.com/ktbjn3d
…11:30am/Oral-Pres: Jeff Hutchins (VP/PreclinRes), “Expansion & Activation of T-cells via the Targeting of the Immunosuppressive Ligand PS: Combination Strategy with Other Checkpoint Inhibitors”

Mar28/Sat: Society of Surgical Oncology's 68th Annual Cancer Symposium (SSO 2015), Houston http://tinyurl.com/q667hua
…12:45pm/Oral-Pres: Adam C. Yopp (MD/UTSW/Dallas), Ph.2 Data) from Bavi+Sorafenib Liver IST, ”A Phase II Study of Bavituximab & Sorafenib in Advanced Hepatocellular Carcinoma (HCC)”

= = = = = = = = = = = = = = =UPCOMING:
Mar30-Apr2/Avid/Booth114: IBC's Biopharm. Dev. & Prod. Week, Huntington Beach http://www.ibclifesciences.com/BDPWeek

Apr18-22: AACR 106th Annual Meeting, Phily (3 Posters), Abstracts: http://tinyurl.com/mlgztsg
…#274(Apr19)/Scott Antonia: “Bavituximab Modulates Tumor Microenvironment and Activates CD8+ Tumor Infiltrating Lymphocytes in a Patient-Derived 3D Ex-Vivo System of Lung Cancer”
...#252(Apr19)/Xianming Huang: “Antibody-Mediated PS Blockade Significantly Enhances the Efficacy Of Immune Checkpoint Blockades in K1735 & B16 Mouse Melanoma Models” [Bavi+Ipilimumab(BMS’s Yervoy)]
...#4289(Apr19)/Bruce Freimark: “Targeting of PS by Mabs Enhances the Activity of Immune Checkpoint Inhibitors in Breast Tumors”

May29-Jun2: ASCO Annual Meeting 2015, Chicago http://am.asco.org

Jun14–19: “GRC: Apoptotic Cell Recognition & Clearance: Physiological Significance & Pathological Consequences”, Biddeford ME
http://www.grc.org/programs.aspx?id=13127
GRC = Gordon Research Conferences (Univ. of New England)
Contributor: Peregrine Pharm. (1 of 4)
“Overcoming Tumor Immune Suppression by Targeting Phosphatidylserine”

~Jul13: FY'15/Q4 (fye 4-30-15) Financials & Conf. Call http://ir.peregrineinc.com/events.cfm

Jun15-18/Avid/Booth533: BIO Intl. Convention, Philadelphia http://convention.bio.org/2015

Oct26-29/Avid/Booth909: IBC's BioProcess Intl. Conf. & Exhib, Boston http://www.ibclifesciences.com/BPI

Dec7-10/Avid/Booth307: IBC's Antibody Eng. & Therapeutics, SanDiego http://www.ibclifesciences.com/AntibodyEng